Elanco Animal Health Inc

Elanco Animal Health, Inc. focuses on providing farm animal and pet health solutions, including treatment and prevention of disease in animals. It was founded in 1953 with its headquarters in Greenfield, Indiana. It operates in more than 90 countries worldwide. Offering pet and farm products, the company provides vaccines and parasiticides for pets, pet therapeutics, products for poultry and aquaculture, nutritional health products, and cattle and swine services. The services for pets are primarily for improving the life of dogs, cats, and their pet parents. The services related to farm life involve beef, dairy, poultry, swine, and aquaculture research innovation, quality improvement, and business improvement. To further strengthen its global presence and reach, the company acquired Ivy Animal Health in 2007, acquired Janssen Animal Health in 2011, acquired ChemGen in 2012, and acquired Bayer Animal Health in 2020. Elanco Animal Health launched Elanco's Healthy Purpose in 2019 to improve the platform and vision of the company. Fortune's 2021 Change the World list recognized Elanco's initiative in solving hunger and climate change through animal care. Elanco has been trading on the NYSE since 2018 under the ticker ELAN. Track the share price of ELAN by adding it to your eToro watchlist.